HALOZYME THERAPEUTICS INC shareholders Q2 2024

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 452 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

HALOZYME THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,039,912$211,529,7924.74%
Future Fund LLC 36,295$1,888,0664.74%
BERNZOTT CAPITAL ADVISORS 187,249$9,804,3584.52%
Steamboat Capital Partners, LLC 177,555$9,296,7803.41%
2Xideas AG 498,957$26,125,3893.26%
Koa Wealth Management, LLC 73,568$3,852,0203.26%
Castellan Group 108,922$5,703,1562.72%
HARVEY CAPITAL MANAGEMENT INC 186,040$9,741,0542.56%
Pier Capital, LLC 220,447$11,542,6051.72%
CHASE INVESTMENT COUNSEL CORP 91,337$4,7821.70%
Granite Investment Partners, LLC 752,839$39,418,6501.63%
SHAKER INVESTMENTS LLC/OH 66,928$3,504,3501.52%
Penn Capital Management Company, LLC 300,670$15,800,8741.50%
TEALWOOD ASSET MANAGEMENT INC 44,301$2,3201.40%
MOODY ALDRICH PARTNERS LLC 135,512$7,095,4081.38%
Mesirow Institutional Investment Management, Inc. 289,805$15,174,1901.33%
ArrowMark Colorado Holdings LLC 2,090,701$109,469,1041.30%
EFG Asset Management (North America) Corp. 140,269$7,345,8881.27%
Hodges Capital Management Inc. 338,856$17,742,5001.19%
Redwood Investments, LLC 59,904$3,117,2001.06%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2024. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.